Open-label Treatment with N-acetylcysteine

DRUG3 trials

Sponsors

Massachusetts General Hospital

Conditions

Alternative TreatmentAutismAutism Spectrum DisorderBipolar DisorderMood DisordersMood DisturbanceNatural SupplementsNon-verbal Learning Disorder

Phase 4

Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders

CompletedNCT02357290

Massachusetts General HospitalBipolar Disorder

Start: 2014-01-31End: 2018-09-24Updated: 2019-11-04

Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)

CompletedNCT03757585

Massachusetts General HospitalAutism, Autism Spectrum Disorder, Non-verbal Learning Disorder

Start: 2019-05-20End: 2024-05-06Updated: 2025-06-05

A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth

CompletedNCT03911414

Massachusetts General HospitalAlternative Treatment, Mood Disorders, Mood Disturbance +1

Start: 2019-06-18End: 2024-12-04Updated: 2026-03-18

Related Papers

Findings from a pilot open-label trial of N-acetylcysteine for the treatment of pediatric mania and hypomania.

2022-05-032 citations